Abstract
Purpose: Chemotherapy treatment may lead to delayed gastric emptying, early satiety, anorexia, nausea and vomiting, described collectively as the cancer-associated dyspepsia syndrome (CADS). Method: We examined the effects of ghrelin in rodent models of CADS induced by treatment with cisplatin. Results: In rats, increased gastric contents and reduced feeding were observed 48 h after injection with cisplatin (6 mg/kg, i.p.). Ghrelin (0.5 mg/kg, i.p.) caused a 16-fold increase in food intake over 1 h in cisplatin/ghrelin-treated rats compared to cisplatin/vehicle-treated rats. A single dose of ghrelin also restored the decreased locomotor activity in rats induced by cisplatin to almost the same level of saline-treated rats. In mice, daily food intake was significantly decreased at 24 h (60%) and 48 h (74%) after cisplatin (20 mg/kg, i.p.). Ghrelin (1 mg/kg, i.p.×2) significantly increased food intake measured at the 48 h time-point in both saline/ghrelin-treated and cisplatin/ghrelin-treated mice, with this effect being most marked in the cisplatin-treated group, where a twofold increase in feeding was observed. In cisplatin-treated mice, delayed gastric emptying was indicated by a 7.7-fold increase in the wet weight of gastric contents and ghrelin improved the gastric emptying index (GEI) by 31% (P<0.01). Conclusion: Together, these results suggest that it is possible to model cancer chemotherapy-induced dyspepsia in rodents and that ghrelin can greatly alleviate the behaviours associated with this syndrome. Agonists at the ghrelin receptor may, therefore, become a useful human therapeutic for this disorder.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Aggarwal SK, Antonio JDS, Sokhansanj A, Miller CM (1994) Cisplatin induced peptic ulcer, vagotomy adrenal and calcium modulation. Anticancer Drugs 5:177–193
Andrews PLR, Torii Y, Saito H, Matsuki N (1996) The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus. Eur J Pharmacol 307:305–313
Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, Katsuura G, Makino S, Fujino MA, Kasuga M (2001a) A role of ghrelin in neuroendocrine and behavioural responses to stress in mice. Neuroendocrinol 74:143–147
Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M (2001b) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120:337–345
Banks WA, Tschop M, Robinson SM, Heiman ML (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302:822–827
Brzozowski T, Konturek PC, Konturek SJ, Kwiecien S, Drozdowicz D, Bielanski W, Pajdo R, Ptak A, Nikiforuk A, Pawlik WW, Hahn EG (2004) Exogenous and endogenous ghrelin in gastroprotection against stress-induced damage. Reg Peptides 120:39–51
Camina JP, Carreira MC, Micic D, Pombo M, Kelestimur F, Dieguez C, Casanueva FF (2003) Regulation of ghrelin secretion and action. Endocrine 22:5–12
Chen C-Y, Inui A, Asakawa A, Fujino K, Kato I, Chen C-C, Ueno N, Fujimiya M (2005) Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterol 129:8–25
Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan X-M, Ye Z, Nargund RP, Smith RG, Van Der Ploeg LHT, Howard AD, Macneil DJ, Qian S (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinol 145:2607–2612
Dass NB, Monunyara M, Bassil AK, Hervieu GJ, Osbourne S, Corcoran S, Morgan M, Sanger GJ (2003) Growth hormone secretagogue receptors in the rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 120:443–453
Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120–1128
Date Y, Toshinani K, Koda S, Miyazato M, Shimbara T, Tsuruta T, Niijima A, Kangawa K, Nakazato M (2005) Peripheral interaction of ghrelin with cholcystokinin on feeding regulation. Endocrinology 146:18–25
De Ambrogi M, Volpe S, Tamanini C (2003) Ghrelin: central and peripheral effects of a novel peptydil hormone. Med Sci Monit 9:RA217–224
De Winter BY, De Man JG, Seerden TC, Depoorte I, Herman AG, Peeters TL, Pelckmans PA (2004) Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil 16:439–446
Edholm T, Levin F, Hellstrom PM, Schmidt PT (2004) Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Reg Peptides 121:25–30
Faulconbridge LF, Cummings DE, Kaplan JM, Grill HJ (2003) Hyperphagic effects of brainstem ghrelin administration. Diabetes 52:2260–2265
Fitzakerley JL, Lucier GE (1988) Connections of a vagal communicating branch in the ferret II. Central projections. Brain Res Bull 20:479–486
Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, Fujimiya M (2003) Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 550:227–240
Gardner CJ, Twissell DJ, Dale TJ, Gale JD, Jordan CC, Kilpatrick GJ, Bountra C, Ward P (1995) The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040. Br J Pharmacol 116:3158–3163
Hainsworth JD, Hesketh PJ (1992) Single dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results. Semin Oncol 19(Suppl 15):14–19
Hesketh PJ, Van Belle S, Aapro M et al (2003) Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 39:1074–80
Hosoda H, Kojima M, Kangawa K (2002) Ghrelin and the regulation of food intake and energy balance. Mol Interv 2:494–503
Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M (2004) Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 18:439–456
Ito C, Isobe Y, Tsuchida K, Higuchi S (1996) 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats. Arch Int Pharmacodyn Ther 331:203–218
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660
Kris M, Grall R, Clark R, Tyson L, Groshen S (1988) Control of chemotherapy-induced diarrhoea with synthetic enkephalin BW942C: a randomised trial with placebo in patients receiving cisplatin. J Clin Oncol 6:663–668
Lang IM (1990) Digestive tract motor correlates of vomiting and nausea. Can J Physiol 68:242–253
Li JJ, Chao HG, Wang H, Tino JA, Lawrence RM, Ewing WR, Ma Z, Yan M, Slusarchyk D, Seethala R, Sun H, Li D, Burford NT, Stoffel RH, Salyan ME, Li CY, Witkus M, Zhao N, Rich A, Gordon DA (2004) Discovery of a potent and novel motilin agonist. J Med Chem 47:1704–1708
Liu YL, Malik NM, Sanger GJ, Friedman MI, Andrews PLR (2005) Pica—a model of nausea? Species differences in response to cisplatin. Physiol Behav 85:271–277
Luque RM, Kineman RD, Park S, Peng X-D, Gracia-Navarro F, Castano JP, Malagon MM (2004) Homologous and heterologous regulation of pituitary treceptors for ghrelin and growth hormone-releasing peptide. Endocrinol 145:3182–3189
Malik NM, Moore GBT, Liu-Y-L, Sanger GJ, Andrews PLR (2006) Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: a model of chemotherapy-related malaise. Pharmacol Biochem Behav (in press)
Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z,Hosoda H, Kojima M, Kangawa K (2000) Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276:905–908
Miyata K, Yamano M, Kamato T, Akuzawa S (1995) Effect of serotonin (5-HT)3 receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents. Jpn J Pharmacol 69:205–214
Moore GBT, Malik NM, Liu-Y-L, Corcoron SL, Morrow RW, Sanger GJ, Andrews PLR (2003) Increased ghlrelin receptor mRNA and therapeutic effects of ghrelin after acute cisplatin treatment. Neurogastroenterol Motil 15:12
Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832–2836
Nelson K, Walsh D, Sheehan F (2002) Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Support Care Cancer 10:455–461
Nelson KA, Walsh TD, Sheehan FG, O’Donovan PB, Falk GW (1993) Assessment of upper gastrointestinal motility in the cancer-associated dyspepsia syndrome. J Palliat Care 9:27–31
Olver IN, Roos IA, Thomas K, Hillcoat BL (1989) Development of a murine gastric distension model for testing the emetic potential of new drugs and efficacy of antiemetics. Chem Biol Interact 69:353–357
Orkin RD, New DI, Noeman D, Chew SL, Clark AJ, Grossman AB, Korbonits M (2003) Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro. J Endocrinol Invest 26:743–747
Peeters TL (2005) Ghrelin: a new player in the control of gastrointestinal functions. Gut 54:1638–1649
Riediger T, Traebert M, Schmid HA, Scheel C, Lutz TA, Scharrer E (2003) Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett 341:151–155
Rudd JA, Andrews PLR (2005) Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In: Hesketh PJ (ed) Management of nausea and vomiting in cancer and cancer treatment. Jones and Bartlett, Sudbury, MA, pp 15–65
Rudd JA, Ngan MP, Wai MK, King AG, Witherington J, Andrews PLR, Sanger GJ (2006) Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin. Neurosci Lett 392:79–83
Ruter J, Kobelt P, Tebbe JJ, Avsar Y, Veh R, Wang L, Klapp BF, Wiedenmann B, Tache Y, Monnikes H (2003) Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats. Brain Res 991:26–33
Sakata I, Yamazaki M, Inoue K, Hayashi Y, Kangawa K, Sakai T (2003) Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett 342:183–186
Sibilia V, Rindi G, Pagani F, Rapetti D, Locatelli V, Torsello A, Campanini N, Deghenghi R, Netti C (2003) Ghrelin protects against ethanol induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 144:353–359
Trudel L, Tomasetto C, Rio MC, Bouin M, Plourde V, Eberling P, Poitras P (2002) Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 282:G948–G952
Trudel L, Bouin M, Tomasetto C, Eberling P, St-Pierre S, Bannon P, L’Heureux MC, Poitras P (2003) Two new peptides to improve post-operative gastric ileus in dog. Peptides 24:531–534
Verhagen MA, Samsom M, Maes B, Geypens BJ, Ghoos YF, Smout AJ (1997) Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther 11:1077–1086
Wang L, Saint-Pierre DH, Tache Y (2002) Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesising neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 325:47–51
Willesen MG, Kristensen P, Romer J (1999) Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70:306–316
Woods SC (2004) Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol 286:G7–G13
Acknowledgements
This study was funded by GlaxoSmithKline, Essex, U.K.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, YL., Malik, N.M., Sanger, G.J. et al. Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemother Pharmacol 58, 326–333 (2006). https://doi.org/10.1007/s00280-005-0179-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-005-0179-0